Updated Jul 16, 2026
Sinha Vikas has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.30M.
Vikas Sinha is a corporate insider associated with Verona Pharma plc and Kalaris Therapeutics, Inc., where he holds the role of Director. He has been involved in multiple SEC filings related to these companies.
| Role | Chief Financial Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-20 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 10.4K | $49.57 | $516K |
| 2026-02-11 | SRRK | Scholar Rock Holding Corp | A — Grant or award | 47.0K | $0.00 | |
| 2026-01-16 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 16.8K | $42.70 | $715K |
| 2025-10-07 | VRNA | Verona Pharma plc | D — Derivative transaction | 72.0K | — | |
| 2025-10-07 | VRNA | Verona Pharma plc | M — Option exercise | 72.0K | — | |
| 2025-10-07 | VRNA | Verona Pharma plc | D — Derivative transaction | 94.1K | — | |
| 2025-08-01 | VRNA | Verona Pharma plc | S — Open-market sale | 4.3K | $13.14 | $57K |
| 2025-08-01 | VRNA | Verona Pharma plc | M — Option exercise | 24.0K | $0.00 | |
| 2024-11-20 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 3.2K | $0.55 | $2K |
| 2024-11-06 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 5.1K | $0.86 | $4K |
| 2024-10-23 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 1.9K | $0.77 | $1K |
| 2024-10-23 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 1.5K | $0.78 | $1K |
| 2024-10-04 | KLRS | Kalaris Therapeutics, Inc. | S — Open-market sale | 940 | $0.81 | $766 |
Vikas Sinha is a corporate insider associated with Verona Pharma plc and Kalaris Therapeutics, Inc., where he holds the role of Director. He has been involved in multiple SEC filings related to these companies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 8 open-market sales ($1.30M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sinha Vikas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.